Companies

Counsel Health

counselhealth.com

Counsel delivers AI-enabled, physician-supervised primary care through messaging for consumers, employers, health plans, and partners.

HQBoston, Massachusetts, United States
Employees11-50
Funding$36M
16 active roles
Profile 6mo agoJobs checked 2h ago
Healthcare AIAI ApplicationB2B SaaSSeries A$10M-$50M

About

Counsel Health builds AI-native, physician-supervised primary care delivered through messaging. It serves consumers, employers, health plans, digital health partners, and health systems, differentiating itself by combining medical AI with in-house physicians, longitudinal health context, and rapid asynchronous care.

Market

Counsel competes in AI-enabled virtual primary care, asynchronous telehealth, and digital-health infrastructure for employers, health plans, health systems, and consumers. Its positioning is differentiated by combining guideline-grounded medical AI and context-aware messaging with real physician oversight, enabling rapid, scalable care while retaining a human clinical safety layer and promising enterprise savings.

Target Customers

Counsel serves individual consumers directly, while its primary enterprise audience includes health plans, employers, health systems, and consumer-health platforms seeking an AI-enabled front door to primary and urgent care. Likely buyers are healthcare, benefits, population-health, digital-health, and clinical-operations leaders who need scalable access, faster resolution, and measurable savings.

At a Glance

Problem

Counsel Health addresses the friction, fragmentation, and cost of conventional healthcare access. Patients often face episodic treatment, delayed appointments, limited continuity, and expensive specialty care, while employers and health plans absorb unnecessary urgent-care, emergency-room, and downstream utilization. Counsel identifies a particularly acute economic gap: traditional specialty visits can cost roughly $100–$600 depending on insurance, while payer costs are expected to rise as chronic-condition management and specialty medications become more expensive.

The killer use case is a modern front door to care: a patient messages a medical question and receives rapid, personalized guidance, triage, follow-up, or escalation without first scheduling an office or video visit. This is especially useful for urgent but non-emergency questions, second opinions, lab or medication questions, and ongoing management of conditions such as hypertension, obesity, and high cholesterol.

Product / Service

Counsel is a full-stack, AI-enabled virtual medical group that delivers care primarily through asynchronous messaging. Its AI helps collect medical history, surface relevant records and clinical guidelines, route specialized tasks, summarize context, and support physicians through a clinician cockpit. Board-certified, in-house physicians remain responsible for diagnosing, prescribing, and guiding care, while the system maintains context across conversations to make care more continuous and personalized. The service covers instant medical advice, results review, lab ordering, medication management, urgent care, second opinions, and selected lifestyle and chronic-condition services.

The model is offered directly to consumers and through employers, health plans, provider organizations, and other healthcare companies. Consumer pricing includes a $29 consultation with condition-specific follow-up and ongoing AI-powered advice, while its premium Signature membership includes expanded services. Counsel says its model delivers physician responses in about two minutes, resolves 96% of issues without escalation, and generates $381 in annual savings per engaged member; by July 2026 it had also announced Counsel Studio, a deployment platform for bringing its physician-supervised care into existing healthcare applications.

Market

Counsel competes in digital health, telemedicine, asynchronous clinical messaging, and AI-enabled virtual primary care. Its differentiation is not simply a chatbot: it combines a messaging-first experience, longitudinal patient context, proprietary workflow software, medical AI, and in-house physician oversight. Directly comparable companies cited in the market include CirrusMD, an on-demand text-first telehealth provider, and 98point6, which uses an AI chatbot to collect and relay information to a provider. Counsel also overlaps with broader virtual-primary-care, urgent-care, and employer-health platforms.

The company is launched and operating rather than merely pre-revenue or pre-product, although the available evidence does not disclose revenue. It launched in 2024 with $11 million in seed funding led by Andreessen Horowitz, subsequently raised a $25 million Series A led by Andreessen Horowitz alongside GV in October 2025, and has partnered with health plans and provider organizations. It initially operated in California, New York, Massachusetts, Florida, and Texas, with plans to expand nationally, and its disclosed operating metrics—96% issue resolution without escalation, two-minute physician response times, and $381 annual savings per engaged member—indicate early commercial and clinical traction.

Founders & Leadership

Dr. Muthu AlagappanFounder
Founder and CEO
Dr. Rishi KhakhkharChief Medical Officer
Dr. Cían HughesChief Scientific Officer
Amit BhattSVP of Finance and Operations
Daniel BongiolattiSVP of Commercial
Javier MonterrosaVP of Marketing
Sam ArnoldVP of D2C Marketing

Funding History

2024-10
Seed$11M

Andreessen Horowitz

2025-10
Series A$25M

Andreessen Horowitz, GV

Recent News

2026-07-28product
Counsel Health Launches Counsel Studio, Bringing AI-Enabled, Physician-Supervised Care Directly Into Healthcare Organizations' Digital Experiences

Counsel Health launched Counsel Studio, a deployment platform that embeds personalized, AI-enabled care into the existing digital experiences of health plans, health systems, and consumer health companies. The platform supports a white-labeled user experience while adding clinical actionability.

2025-10-16funding
a16z Leads Counsel Health's $25M Series A, Alongside GV, to Redefine What It Means to Access Healthcare

Andreessen Horowitz led Counsel Health's $25 million Series A financing alongside GV. The funding supports Counsel's effort to redefine access to healthcare through its AI-enabled, physician-supervised care model.

Active Roles

16
New York Office (Flatiron)/Data & Analytics/7d ago
Boston/Design/8d ago
New York Office (Flatiron)/Professional Services/16d ago
Boston/Finance/30d ago
Boston/Marketing/30d ago
Founding Data Analyst$150k – $175k
Boston/Data & Analytics/34d ago
New York Office (Flatiron)/Engineering/63d ago
New York Office (Flatiron)/Engineering/63d ago
New York Office (Flatiron)/Engineering/63d ago
Analytics Engineer$185k – $210k
New York Office (Flatiron)/Data & Analytics/63d ago
New York Office (Flatiron)/Engineering/90d ago
Remote - US/Other/115d ago
New York Office (Flatiron)/Engineering/161d ago
New York Office (Flatiron)/Product/197d ago

Business Model

Counsel monetizes direct-to-consumer care through $29 seven-day visits and a $199-per-year Counsel Signature subscription. It also provides AI-enabled, physician-supervised care to employers, health plans, healthcare organizations, and other partners through enterprise arrangements, though enterprise pricing is not disclosed.

Products

Counsel AI consumer medical chatbot for symptom questions, medical-history collection, and personalized guidanceOn-demand physician consultations through secure messaging, including one-click escalation from AI to a real doctorEmployer virtual primary-care offering via text or voiceEmbedded enterprise virtual-care infrastructure for health plans, health systems, and consumer-health platformsVirtual primary and urgent care, including treatment plans and prescription support

Tech Stack

Medical AI trained on verifiable sources and peer-reviewed medical guidelinesSecure asynchronous messagingText and voice chat interfacesPhysician-in-the-loop clinical oversightContext-aware health-history analysis and pattern recognition

Competitors

98point6
K Health
Teladoc Health
One Medical

Key Investors

Andreessen Horowitz, Google Ventures, Floodgate, Asymmetric Capital Partners